Kontos M C, Akosah K O, Brath L K, Funai J T, Mohanty P K
Medical College of Virginia, Richmond, USA.
J Cardiothorac Vasc Anesth. 1996 Apr;10(3):329-35. doi: 10.1016/s1053-0770(96)80092-9.
The objective of this study was to determine the relative value of dobutamine stress echocardiography (DSE) and dipyridamole thallium imaging (DT) in the preoperative assessment of cardiovascular risk before noncardiac surgery.
Prospectively DSE was performed in patients who had undergone DT as a part of their preoperative evaluation.
A large urban veterans' affairs medical center.
Thirty-seven patients undergoing major noncardiac surgery were assessed for complications during a 1-month follow-up period.
Both DSE and DT were performed before surgery. The medium interval between the two tests were 15.5 days.
Left ventricular wall motion was assessed at baseline and peak dobutamine dose in a standard fashion. Wall motion was scored and indexed using a 16-segment model. A positive DSE was defined as failure of augmentation, new or worsening of baseline wall motion abnormalities in two or more contiguous segments. Myocardial perfusion studies after DT were performed according to conventional method. A positive DT was defined as a reversible perfusion defect, increased lung uptake, and/or transient left ventricular dilatation. Complications were defined as myocardial infarction or cardiac death occurring as a result of the operation, or need for revascularization before surgery.
DSE was positive in 19 patients, whereas DT was positive in 25 patients. Fourteen patients had both an abnormal DSE and DT. Five patients had major postoperative cardiac complications: fetal myocardial infarction (1); fatal cardiac arrest (1); and severe coronary artery disease necessitating coronary artery bypass surgery (2) or percutaneous transluminal coronary angioplasty (1). DSE was positive in all 5 (100%), whereas DT was positive in 4 of 5 (80%) patients with complications. The sensitivity for each test was comparable: for DSE it was 100% (95% C.I. 56% to 100%) and for DT 80% (37% to 96%). Specificity for DSE (60%, 43%-74%) was somewhat higher than DT (38%, 24% to 54%), although this did not reach statistical significance (p = 0.06).
The ability of DSE to predict major cardiac complications related to noncardiac surgery appears to be similar to DT and may be used as an alternative to DT imaging in the preoperative risk assessment of patients undergoing noncardiac surgery.
本研究的目的是确定多巴酚丁胺负荷超声心动图(DSE)和双嘧达莫铊显像(DT)在非心脏手术前心血管风险术前评估中的相对价值。
对作为术前评估一部分已接受DT检查的患者前瞻性地进行DSE检查。
一家大型城市退伍军人事务医疗中心。
37例接受大型非心脏手术的患者在1个月的随访期内接受并发症评估。
手术前同时进行DSE和DT检查。两次检查的平均间隔时间为15.5天。
以标准方式在基线和多巴酚丁胺剂量峰值时评估左心室壁运动。使用16节段模型对壁运动进行评分和指数化。DSE阳性定义为增强失败、两个或更多连续节段的基线壁运动异常新出现或加重。DT后的心肌灌注研究按照常规方法进行。DT阳性定义为可逆性灌注缺损、肺摄取增加和/或短暂性左心室扩张。并发症定义为手术导致的心肌梗死或心脏死亡,或手术前需要进行血管重建。
19例患者DSE阳性,而25例患者DT阳性。14例患者DSE和DT均异常。5例患者术后出现严重心脏并发症:胎儿心肌梗死(1例);致命性心脏骤停(1例);严重冠状动脉疾病需要冠状动脉搭桥手术(2例)或经皮腔内冠状动脉成形术(1例)。5例(100%)有并发症的患者DSE均阳性,而DT在5例中有4例(80%)阳性。每项检查的敏感性相当:DSE为100%(95%可信区间56%至100%),DT为80%(37%至96%)。DSE的特异性(60%,43% - 至74%)略高于DT(38%,24%至54%),尽管这未达到统计学显著性(p = 0.)。
DSE预测与非心脏手术相关的主要心脏并发症的能力似乎与DT相似,可作为非心脏手术患者术前风险评估中DT显像的替代方法。